1. Home
  2. VS vs BIAF Comparison

VS vs BIAF Comparison

Compare VS & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Versus Systems Inc.

VS

Versus Systems Inc.

N/A

Current Price

$1.32

Market Cap

6.3M

Sector

Technology

ML Signal

N/A

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.39

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VS
BIAF
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
6.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
VS
BIAF
Price
$1.32
$1.39
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
38.5K
72.4K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,179,348.00
$6,776,739.00
Revenue This Year
$3,459.21
N/A
Revenue Next Year
N/A
$20.04
P/E Ratio
N/A
N/A
Revenue Growth
2281.70
N/A
52 Week Low
$1.15
$1.11
52 Week High
$3.79
$46.53

Technical Indicators

Market Signals
Indicator
VS
BIAF
Relative Strength Index (RSI) 44.64 47.37
Support Level $1.18 $1.11
Resistance Level $1.32 $1.32
Average True Range (ATR) 0.06 0.12
MACD 0.02 0.03
Stochastic Oscillator 73.80 72.16

Price Performance

Historical Comparison
VS
BIAF

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: